DTE
75
3
TSN
44
-2
DHR
41
2
FOXA
69
2
SJM
23
-5
PH
73
3
MS
62
7
CMA
73
2
CMI
62
2
ZTS
12
-4
DVA
59
-13
UAL
70
7
FDX
40
3
LOW
45
2
L
39
-2
SLG
31
3
JBHT
50
5
XOM
42
3
IR
40
-7
GME
59
3
DTE
75
3
TSN
44
-2
DHR
41
2
FOXA
69
2
SJM
23
-5
PH
73
3
MS
62
7
CMA
73
2
CMI
62
2
ZTS
12
-4
DVA
59
-13
UAL
70
7
FDX
40
3
LOW
45
2
L
39
-2
SLG
31
3
JBHT
50
5
XOM
42
3
IR
40
-7
GME
59
3
Financhill
Back

Royal Bank of Canada Vs. Sarepta Therapeutics Industry Stock Comparison

Sell
50

RY
Royal Bank of Canada

Last Price:
$119.02
Seasonality Move:
4.71%
Sell
41

SRPT
Sarepta Therapeutics

Last Price:
$107.93
Seasonality Move:
1.75%
Sell
50
Royal Bank of Canada (RY) is a Sell

Is Royal Bank of Canada a Buy, Sell or Hold?

  • The current Royal Bank of Canada [RY] share price is $119.04. The Score for RY is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
  • RY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
41
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $107.95. The Score for SRPT is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

RY Stock Price Chart

What is Royal Bank of Canada's stock price today?

  • The Royal Bank of Canada share price today is $119.04
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RY is experiencing selling pressure, which indicates risk of future bearish movement.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $107.95
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing selling pressure, which indicates risk of future bearish movement.

RY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.76 Sell
Relative Strength Index (14 RSI): 43.85 Sell
Chaikin Money Flow: -1121515 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (118.52 - 121.94) Sell
Bollinger Bands (100): (120.27 - 124.73) Sell

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.94 Sell
Relative Strength Index (14 RSI): 33.84 Sell
Chaikin Money Flow: -502758 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (111.52 - 119.16) Sell
Bollinger Bands (100): (114.38 - 127.78) Sell

RY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 118.87 Buy
20-day SMA: 120.5 Sell
50-day SMA: 121.49 Sell
200-day SMA: 116.12 Buy
8-day EMA: 119.13 Sell
20-day EMA: 119.91 Sell
50-day EMA: 120.9 Sell
200-day EMA: 116.08 Buy

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 111.57 Sell
20-day SMA: 114.25 Sell
50-day SMA: 119.8 Sell
200-day SMA: 128.55 Sell
8-day EMA: 110.88 Sell
20-day EMA: 113.91 Sell
50-day EMA: 117.81 Sell
200-day EMA: 123.39 Sell

Royal Bank of Canada Earnings Growth & RY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.15 per share, an increase next quarter of $0.14 per share, an increase this year of $0.60 per share, and an increase next year of $0.88 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.70 per share, a decrease next quarter of $0.00 per share, an increase this year of $7.63 per share, and an increase next year of $4.84 per share.

Royal Bank of Canada Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):